Izun Pharmaceuticals is a biopharmaceutical company in the advanced clinical development stage, focusing on the rapidly expanding field of oncology support. Our offerings facilitate more effective cancer treatment and enhance the well-being of cancer patients. With the rise of patient-centric medicine, therapies supporting oncology are quickly becoming an essential component of comprehensive cancer care and are projected to achieve a market size of $22 billion by 2026.